Avalo Therapeutics (NASDAQ:AVTX) Earns Buy Rating from Analysts at Stifel Nicolaus
Investment analysts at Stifel Nicolaus started coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat reports. The firm set a “buy” rating and a $36.00 price target on the stock. Stifel Nicolaus’ target price would suggest a potential upside of 330.62% from the […]
Investment analysts at Stifel Nicolaus started coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat reports. The firm set a “buy” rating and a $36.00 price target on the stock. Stifel Nicolaus’ target price would suggest a potential upside of 330.62% from the […]
